Supernus, Indivior Merge
Supernus and Indivior merge to create CNS biopharmaceutical leader
4 Billion in Convertible Notes (PR) CRH/ACA: Definitive Proxy; Shareholder Date 9/4 (Proxy) SWKS/QRVO: Qorvo Unaudited Financials and Pro Forma Combined Financials Filed (PR); HSR Timing Agreement Expires, China and S.
Korea Outstanding Approvals Needed (Filing) AMZN/GSAT: Form S-4 Filed (S-4) OLN/HUN: Olin Q2 2026 earnings call; closing expected first half 2027; shareholder vote 8/25 (PR) PSKY/WBD: PSKY Automatic Shelf Prospectus (Filing); Pro Forma Financial Statements Filed for Pending PSKY-WBD Merger (PR) AWK/WTRG: Integration planning update: branding, org structure, town hall August 5 (PR) EQR/AVB: Supplemental Disclosure to Joint Proxy Statement/Prospectus Re: Merger Litigation (PR); Unaudited Pro Forma Condensed Consolidated Financial Statements Filed for EQR/AVB Merger (PR) Nuvei/PAYO: Preliminary Proxy; Shareholder Date TBD (Proxy) VRTX/CRNX: Definitive Proxy; Shareholder Date 8/28 (Proxy) GOLDEN EDGE/PERF: Preliminary Proxy Statement Filed (Filing) SOLS/ESI: Excerpts from earnings call; closing expected first half 2027 (PR) BSX/PEN: BSX 10-Q BX/TXNM: TXNM 10-Q WFRD/NCSM: NCSM 10-Q